Effect of anticoagulants in vitro on the viability of lymphocytes and content of free fatty acids in plasma.
These authors attempted to test the effect of anticoagulants on lymphocytes viability by reproducing the procedure used for lymphocyte isolation for various immunologic tests in which blood specimens are allowed to stay at room temperature for 2 h before lymphocytes are isolated. Blood was obtained with three different anticoagulants i.e. heparin, citrate, and CPDA (citrate, phosphate, dextrose, and adenine). Plasma was lyophilized and extracted with ethanol. Dried ethanol extracts were suspended in medium (RPMI 1640 + 10% fetal bovine serum) and incubated with a lymphocyte cell line (MOLT-4). After 24 h of incubation the viability of cells was examined. The following death rates of the cells were observed: heparin -63 +/- 4.6% (mean +/- SEM), citrate -27 +/- 6.7%, and CPDA 6.2 +/- 0.6% (P less than 0.0005). A significant correlation was found between these results and changes in the concentrations of free fatty acids in the extracts. These results emphasize the importance of choosing the right anticoagulant when the viability of lymphocytes is obligatory.
Klein
A
A
Department of Clinical Biochemistry, Sunnybrook Medical Centre, University of Toronto, Canada.
Ramcharitar
S
S
Christeff
N
N
Nisbett-Brown
E
E
Nunez
E
E
Malkin
A
A
D000225:Adenine / Q000494:pharmacology; D000925:Anticoagulants / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects*; D002951:Citrates / Q000494:pharmacology; D019343:Citric Acid; D000431:Ethanol; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D005612:Freeze Drying; D005947:Glucose / Q000494:pharmacology; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D008214:Lymphocytes / Q000166:cytology*; D010710:Phosphates / Q000494:pharmacology
D000925:Anticoagulants; C034876:CPDA solutions; D002951:Citrates; D005230:Fatty Acids, Nonesterified; D010710:Phosphates; D019343:Citric Acid; D000431:Ethanol; D006493:Heparin; D005947:Glucose; D000225:Adenine